IRIDS Virtual Science Talks

Welcome to the IRIDS Virtual Science Talks
The spirit of IRIDS

IRIDS (International Roche Infectious Diseases Symposium) comprises a series of scientific and educational events taking place since 2009, addressing some of the most significant, up-to-date topics in the field of infectious disease (ID) management and diagnosis. IRIDS is the perfect forum for laboratory experts and clinical specialists from around the world, to exchange insights and expertise in the infectious diseases field.  


The IRIDS Virtual Science Talks

In 2022, Roche has initiated a series of webinars with the aim of engaging, informing, and inspiring healthcare professionals worldwide.
Scientists and industry leaders will share their thoughts and experiences within the field of infectious diseases, on a platform built to facilitate and enhance conversations and sometimes also debates.


Three reasons to attend

Stay up to date on the global trends and most significant development on infectious diseases.

Discover more about trends and current innovations around SARS-CoV-2, viral hepatitis, sexual transmitted diseases, and congenital infection, just to mention a few.

Connect with lab experts, clinicians, industry leaders from other countries.

Attendance to the IRIDS Virtual is free of charge. No CME points will be provided, but it will be possible to get a Certificate of Attendance.


Sign up now to unlock the IRIDS virtual platform and its exclusive content

Register now for the upcoming IRIDS Virtual Science Talk entitled 'Beyond the Pandemic: Understanding Long COVID and Risk for SARS-CoV-2 Infection’ planned for June 6th, 2024 from 13:00 to 14:00 CET


Form Successfully Submitted!
Thank you for your submission!


  1. Davis H. E. et al. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023 March;21:133–146.
  2. WHO. HIV and AIDS factsheet [Internet; updated 2023 July; cited 2023 Oct]. Available from:
  3. CDC. Pre-Exposure Prophylaxis (PrEP). [Internet; updated 2022 July; cited 2023 Oct]. Available from:
  4. World Health Organization. Hepatitis C. [Internet; updated 2022 June; cited 2023 March 30]. Available from: 
  5. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. [Internet; updated 2022 July; cited 2022 Sept 16]. Available from:
  6. Majchrzak M, et al. Multicenter performance evaluation of the Elecsys HCV Duo immunoassay. J. Clin. Virol. 2022;156:105293.
  7. Fowler, K., et al. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health 2022;22, 1659.
  8. Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009;46(Suppl 4):S6–10. pmid:19800841.
  9. United Nations. World Population Prospects 2022. [Internet; cited 2022 Nov 29]. Available from:
  10. Perillaud-Dubois C, et al. Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review. PLoS ONE 2022;16(12): e0261011.
  11. CDC. Congenital CMV Infection. [Internet; cited 2022 Nov 29]. Available from:
  12. Cannon M.J., Davis K.F. Washing our hands of the congenital cytomegalovirus epidemics. BMC Public Health. 2005;5:70.
  13. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020. [Internet; 2020 March; cited 2022 October 13]. Available from:
  14. United Nations News. The end of the COVID-19 pandemic is in sight: WHO.  [Internet; 2022 September; cited 2022 October 13]. Available from: